Srs Capital Advisors, Inc. Bristol Myers Squibb CO Transaction History
Srs Capital Advisors, Inc.
- $977 Million
- Q2 2024
A detailed history of Srs Capital Advisors, Inc. transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Srs Capital Advisors, Inc. holds 3,891 shares of BMY stock, worth $209,958. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,891
Previous 981
296.64%
Holding current value
$209,958
Previous $53,000
203.77%
% of portfolio
0.02%
Previous 0.01%
Shares
25 transactions
Others Institutions Holding BMY
# of Institutions
2,407Shares Held
1.5BCall Options Held
29.7MPut Options Held
32.2M-
Vanguard Group Inc Valley Forge, PA187MShares$10.1 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY159MShares$8.56 Billion0.15% of portfolio
-
State Street Corp Boston, MA91.4MShares$4.93 Billion0.17% of portfolio
-
Jpmorgan Chase & CO New York, NY74.6MShares$4.03 Billion0.27% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA59.1MShares$3.19 Billion0.47% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $115B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...